Cardioprotective delta opioid receptor agonists and methods of using same

Details for Australian Patent Application No. 2004203699 (hide)

Owner Ardent Pharmaceuticals, Inc.

Inventors Chang, Kwen-Jen; Pendergast, William; Gengo, Peter J.; Ma, Xin

Agent Callinan

Pub. Number AU-A-2004203699

PCT Pub. Number WO2004/060321

Priority 60/437,728 02.01.03 US; 10/749,437 31.12.03 US

Filing date 2 January 2004

Wipo publication date 22 July 2004

International Classifications

A61K 031/395 - having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/060321 Priority application(s): WO2004/060321

26 July 2007 Assignment before Grant

  Ardent Pharmaceuticals, Inc. The application has been assigned to Mount Cook Biosciences, Inc.

30 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004203700-Pharmaceutical preparations for treatments of diseases and disorders of the breast

2004203690-Agonist peptide dimers